Companies: 10,795·Total market cap: $144.5T
West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc.

WSTNYSEHealthcare● Active
$317.83
+$3.33(+1.06%)
Market Cap$22.5B
P/E Ratio
52W High$330.88
52W Low$206.8

West Pharmaceutical Services, Inc. (WST) Stock Ownership

Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.

SEC 13F · FMP · WST · as of Mar 31, 2025

Ownership Breakdown

Institutions 98.91%
Insiders 0.64%
Public 0.45%

736

Institutional Holders

▼ 34 vs Q4

$15.61B

Total Inst. Value

▼ $7.24B vs Q4

70.65M

Shares Outstanding

freeFloat 99.36%

69.88M

13F Shares Held

▼ 19,911 vs Q4

Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.

Top Institutional Holders

WST largest shareholders · institutional ownership

Q1 2025 · SEC 13F

Showing top 10 holders

HolderShares% OwnedWeightValueReportedChange

VANGUARD GROUP INC

fabricated rubber products, nec

9.23M12.73%

12.73%

$2.07TMay 9, 2025 244.3K

BLACKROCK, INC.

fabricated rubber products, nec

6.93M9.56%

9.56%

$1.55TMay 2, 2025 520.6K

BANK OF NEW YORK MELLON CORP

fabricated rubber products, nec

3.38M4.66%

4.66%

$755.67BApr 29, 2025 74.5K

BROWN ADVISORY INC

fabricated rubber products, nec

3.27M4.51%

4.51%

$731.75BApr 30, 2025 716.4K

STATE STREET CORP

fabricated rubber products, nec

3.20M4.42%

4.42%

$717.21BMay 15, 2025 43.2K

ARTISAN PARTNERS LIMITED PARTNERSHIP

fabricated rubber products, nec

2.20M3.03%

3.03%

$491.52BMay 14, 2025 915.4K

GEODE CAPITAL MANAGEMENT, LLC

fabricated rubber products, nec

1.85M2.56%

2.56%

$413.70BMay 13, 2025 74.8K

DURABLE CAPITAL PARTNERS LP

fabricated rubber products, nec

1.57M2.17%

2.17%

$352.19BMay 15, 2025 935.7K

APG ASSET MANAGEMENT N.V.

fabricated rubber products, nec

1.56M2.15%

2.15%

$323.77BMay 14, 2025 124.7K

FRANKLIN RESOURCES INC

fabricated rubber products, nec

1.56M2.15%

2.15%

$349.39BMay 13, 2025 220.3K

Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).

Institutional Activity

Q1 2025 vs prior quarter

Q1 2025

Net institutional sentimentBullish — more buying than selling

29

Increased

+5.64M shares

2

New Positions

first time holders

18

Decreased

−3.50M shares

0

Sold Out

fully exited

Net shares change (top 50)

+2.13M

+5.64M / −3.50M

Net new holders

+13

2 new / 0 exited

Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).

Insider Buying vs Selling

WST insider trading · insider activity

Source: SEC Form 4

Buy 0%Active transactions only100% Sell

Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.

0

Buy transactions

0

Sell transactions

0.00

Buy/Sell ratio

$0M

Total disposed

Recent Insider Transactions

Showing 10 most recent · Common Stock only

Name · RoleDateTypeSharesPriceValueAfter Trans.Filing

Campbell Shane Alden

SVP, Proprietary Segment

May 12, 2026Tax Withhold134.927$312.07$42.1K612.796Form 4 ↗

Campbell Shane Alden

SVP, Proprietary Segment

May 12, 2026Tax Withhold84.329$312.07$26.3K274.13Form 4 ↗

Pucci Paolo

director

May 4, 2026Award79111.9KForm 4 ↗

Michels Douglas A

director

May 4, 2026Award79146.5KForm 4 ↗

Lockhart Stephen H

director

May 4, 2026Award7913.5KForm 4 ↗

LAI GOLDMAN MYLA

director

May 4, 2026Award79120.4KForm 4 ↗

Keller Deborah L

director

May 4, 2026Award79111.6KForm 4 ↗

Joseph Molly

director

May 4, 2026Award7914.4KForm 4 ↗

HAUGEN JANET BRUTSCHEA

director

May 4, 2026Award7912.4KForm 4 ↗

FRIEL ROBERT F

director

May 4, 2026Award7915.5KForm 4 ↗

Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.

About institutional & insider ownership

West Pharmaceutical Services, Inc. (WST) is primarily owned by institutional investors, who hold approximately 98.9% of total shares outstanding. Company insiders own approximately 0.64%, while retail and public investors account for the remaining 0.45%.

The largest institutional shareholder of West Pharmaceutical Services, Inc. is VANGUARD GROUP INC, holding approximately 9.23 million shares — equal to 12.73% of outstanding shares — as of March 31, 2025.

A total of 736 institutional investors currently hold WST stock, with a combined institutional value of approximately $15.61 billion as of the most recent 13F filing period.

Frequently asked questions

WST ownership

West Pharmaceutical Services, Inc. (WST) is primarily owned by institutional investors, who hold approximately 98.9% of shares. The largest shareholder is VANGUARD GROUP INC with a 12.73% stake. Company insiders hold 0.64%. Data sourced from SEC Form 13F as of March 31, 2025.

who owns WST stockWST ownership structureSEC Form 13F institutional holdingsWST float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of March 31, 2025